KR100405030B1 - New UV-curing antibacterial agents - Google Patents
New UV-curing antibacterial agents Download PDFInfo
- Publication number
- KR100405030B1 KR100405030B1 KR10-2001-0006599A KR20010006599A KR100405030B1 KR 100405030 B1 KR100405030 B1 KR 100405030B1 KR 20010006599 A KR20010006599 A KR 20010006599A KR 100405030 B1 KR100405030 B1 KR 100405030B1
- Authority
- KR
- South Korea
- Prior art keywords
- antimicrobial
- weight
- formula
- substrate
- coating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Paints Or Removers (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
본 발명은 UV 경화형 항균제에 관한 것으로서, 더욱 상세하게는 항균활성은 물론 UV 경화 특성을 가지고 있어 항균처리가 요구되는 기질의 표면에 무용제 형태로 코팅한 후에 UV를 조사하게 되면 항균 화합물이 고분자화(polymerization) 되어 기질 표면에 부착되므로 기질 표면이 반영구적으로 항균활성을 나타내게 되는 다음 화학식 1로 표시되는 UV 경화형 항균제에 관한 것이다.The present invention relates to a UV curable antimicrobial agent, and more particularly, the antimicrobial activity, as well as UV curing properties of the antimicrobial compound is coated with a solvent-free form on the surface of the substrate that requires antimicrobial treatment when the antimicrobial compound is polymerized ( The present invention relates to a UV curable antimicrobial agent represented by the following Chemical Formula 1, which is polymerized) and adheres to a substrate surface so that the substrate surface exhibits antibacterial activity semi-permanently.
화학식 1Formula 1
상기 화학식 1에서: R은 수소원자 또는 메틸기를 나타내고; X는 할로겐원자를 나타낸다.In Chemical Formula 1, R represents a hydrogen atom or a methyl group; X represents a halogen atom.
Description
본 발명은 UV 경화형 항균제에 관한 것으로서, 더욱 상세하게는 항균활성은 물론 UV 경화 특성을 가지고 있어 항균처리가 요구되는 기질의 표면에 무용제 형태로 코팅한 후에 UV를 조사하게 되면 항균 화합물이 고분자화(polymerization) 되어 기질 표면에 부착되므로 기질 표면이 반영구적으로 항균활성을 나타내게 되는 다음 화학식 1로 표시되는 UV 경화형 항균제에 관한 것이다.The present invention relates to a UV curable antimicrobial agent, and more particularly, the antimicrobial activity, as well as UV curing properties of the antimicrobial compound is coated with a solvent-free form on the surface of the substrate that requires antimicrobial treatment when the antimicrobial compound is polymerized ( The present invention relates to a UV curable antimicrobial agent represented by the following Chemical Formula 1, which is polymerized) and adheres to a substrate surface so that the substrate surface exhibits antibacterial activity semi-permanently.
화학식 1Formula 1
상기 화학식 1에서: R은 수소원자 또는 메틸기를 나타내고; X는 할로겐원자를 나타낸다.In Chemical Formula 1, R represents a hydrogen atom or a methyl group; X represents a halogen atom.
균류는 크게 세균류(bacteria)와 진균류(fungi)의 두 종류로 나눌 수 있다. 이 두 부류의 균들에 작용하는 기존의 항균 물질로는 페놀 계, 벤조산 계, 사차 암모늄 염 계, 이미다졸 계, β-락탐 계, 자연 생성 추출물 계 등이 널리 알려져 있다. 이 항균 물질들은 주로 의복류, 주택의 바닥 장식제, 욕실의 욕조, 세면기, 전화기 및 공공 장소 등 균이 번식할 수 있는 곳에 코팅용 및 기타 방식의 첨가제로 사용되어 왔다.Fungi can be divided into two types, bacteria and fungi. Existing antimicrobial agents that act on these two classes of bacteria are widely known as phenolic, benzoic acid, quaternary ammonium salts, imidazoles, β-lactams, and naturally occurring extracts. These antimicrobials have been used mainly as coatings and other additives where germs can grow, including clothing, home flooring, bath tubs, washbasins, telephones and public areas.
즉, 기존의 항균제들은 일반적으로 첨가제 형태로 사용되어 왔는 바, 첨가제로서 사용하게 되면 편리한 점은 있으나 주로 과량을 사용하게 되고 첨가된 항균 물질의 일부만이 기질표면에서 항균 작용을 나타내며 일정 시간이 경과하면 작용 부위의 지속된 세척 등으로 항균력이 급격히 감소하는 현상이 관찰된다. 따라서, 항균제를 첨가제 형태로 사용하기 보다는 항균활성이 요구되는 기질의 표면에 코팅 처리 후, 고분자 구조로 전환하여 부착시키게 되면 반영구적인 항균효과를 얻을 수 있게 될 것이다. 그러나, 항균제 분야에서는 아직까지도 첨가제 방식이 주로 사용되고 있는데, 그 이유는 기존의 항균제들이 첨가제로 사용될 때는 일정 기간 항균 효과가 유지되지만 UV 경화형 항균물질을 단량체 형태로 코팅한 후 UV 조사를 통하여 고분자로 전환하게 되면 항균 물질 자체의 화학적 구조가 변형되어 전혀 항균 효과를 나타내지 못하는 경우가 대부분이기 때문이다.In other words, conventional antimicrobial agents have been generally used in the form of additives, but it is convenient to use them as additives, but mainly in excess, and only a part of the added antimicrobial substances exhibits antimicrobial activity on the substrate surface. It is observed that the antimicrobial activity is drastically reduced by continuous washing of the action site. Therefore, after the coating treatment on the surface of the substrate that requires antimicrobial activity, rather than using the antimicrobial agent in the form of additives, it will be possible to obtain a semi-permanent antimicrobial effect by converting and attaching the polymer structure. However, in the field of antimicrobial agents, additives are still mainly used. The reason is that when antimicrobial agents are used as additives, the antimicrobial effect is maintained for a certain period of time, but UV-curable antimicrobial is coated in monomer form and converted into polymer through UV irradiation. This is because the chemical structure of the antimicrobial substance itself is modified, which is why most cases do not exhibit an antimicrobial effect.
이에 본 발명에서는 항균제 분야이외에 타 고분자 산업에서 널리 이용되고 있는 UV 경화에 의한 코팅 방법을 도입하는 것에 대해 오랜 기간 연구하였고, 그 결과 UV 경화특성을 가지는 신규 항균제를 개발함으로써 본 발명을 완성하게 되었다.Therefore, the present invention has been studied for a long time to introduce a coating method by UV curing, which is widely used in other polymer industries in addition to the antibacterial field, and as a result, the present invention was completed by developing a new antibacterial agent having UV curing properties.
즉, 본 발명에서는 항균제를 첨가제 형태로 사용하기 보다는 기질의 표면에 무용제 형태로 항균 코팅을 한 후 한번의 UV 조사로 빠른 시간에 고분자화가 가능하며 고분자화된 항균제가 기질 표면에 고르게 부착되어 분포하므로 적용된 기질 전 표면에서 균일한 항균효과를 얻을 수 있게 된다. 그리고, 본 발명의 항균 코팅액은 무용제 형태로 사용되므로 UV 경화 후 인체에 유해한 용매의 증발현상이 나타나지 않으므로 이또한 장점이될 수 있다. 또한, 소량의 항균 코팅으로도 반영구적으로 항균력을 지속시키는 장점이 있으며, 기존의 첨가제 방식에서 나타나는 유해 용매의 증발 및 항균제의 소실로 인한 인체의 피해 및 환경 오염 등 기타 부작용도 최소화 할 수 있을 것으로 기대된다.That is, in the present invention, rather than using an antimicrobial agent in the form of additives, the antimicrobial coating is applied to the surface of the substrate in the form of a solvent-free, and then polymerized in a short time by one UV irradiation, since the polymerized antimicrobial is evenly attached to the substrate surface. Uniform antimicrobial effect can be obtained on the entire surface of the applied substrate. In addition, since the antimicrobial coating solution of the present invention is used in the form of a solvent-free, since the evaporation phenomenon of a solvent harmful to the human body does not appear after UV curing, this may also be an advantage. In addition, even a small amount of antimicrobial coating has the advantage of sustaining antimicrobial power semi-permanently, and it is expected to minimize other side effects such as damage to the human body and environmental pollution due to evaporation of harmful solvent and loss of antimicrobial agent appearing in the existing additive method do.
따라서, 본 발명은 적은 에너지로도 쉽게 고분자화 반응을 일으킬 수 있는 아크릴 또는 메타아크릴 작용기와 이미다졸계 사차 암모늄 염을 포함하는 신규 UV 경화형 항균제를 제공하는데 그 목적이 있다.Accordingly, an object of the present invention is to provide a novel UV curable antimicrobial agent comprising an imidazole quaternary ammonium salt with an acrylic or methacryl functional group which can easily cause a polymerization reaction even with low energy.
또한, 본 발명은 신규 항균제를 항균활성이 요구되는 기질의 표면에 코팅 처리한 후 UV 조사에 의해 기질표면에 고착시키는 항균처리 방법을 제공하는데 또다른 목적이 있다.In addition, the present invention is another object to provide an antimicrobial treatment method for fixing a novel antimicrobial agent to the surface of the substrate by UV irradiation after the coating treatment on the surface of the substrate that requires antimicrobial activity.
도 1a 및 1b는 각각 실시예 1에서 합성한 1,3-비스(11-히드록시운데실)이미다졸리늄 브로마이드에 대한 IR 스펙트럼 및1H NMR 스펙트럼이다.1A and 1B are IR spectra and 1 H NMR spectra for 1,3-bis (11-hydroxyundecyl) imidazolinium bromide synthesized in Example 1, respectively.
도 2a 및 2b는 각각 실시예 2에서 합성한 1,3-비스(11-히드록시운데실)이미다졸리늄 클로라이드에 대한 IR 스펙트럼 및1H NMR 스펙트럼이다.2A and 2B are IR spectra and 1 H NMR spectra for 1,3-bis (11-hydroxyundecyl) imidazolinium chloride synthesized in Example 2, respectively.
도 3a, 3b 및 3c는 각각 실시예 3에서 합성한 1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 브로마이드에 대한 IR 스펙트럼,1H NMR 스펙트럼 및13C NMR 스펙트럼이다.Figure 3a, a 1,3-bis prepared in Example 3 3b and 3c are each IR spectrum for the [11 - [(1-oxo-2-propenyl) oxy] undecyl] imidazolidine bromide, 1 H NMR spectrum and 13 C NMR spectrum.
도 4a 및 4b는 각각 실시예 4에서 합성한 1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 클로라이드에 대한 IR 스펙트럼 및1H NMR 스펙트럼이다.4A and 4B show IR spectra and 1 H NMR for 1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium chloride synthesized in Example 4, respectively. Spectrum.
도 5a, 5b 및 5c는 각각 실시예 5에서 합성한 1,3-비스[11-[(1-옥소-2-메틸-2-프로페닐)-옥시]운데실]이미다졸리늄 브로마이드에 대한 IR 스펙트럼,1H NMR 스펙트럼 및13C NMR 스펙트럼이다.5A, 5B and 5C show the 1,3-bis [11-[(1-oxo-2-methyl-2-propenyl) -oxy] undecyl] imidazolinium bromide synthesized in Example 5, respectively. IR spectrum, 1 H NMR spectrum and 13 C NMR spectrum.
본 발명은 다음 화학식 1로 표시되는 UV 경화형 항균제를 그 특징으로 한다.The present invention is characterized by a UV curable antimicrobial agent represented by the following formula (1).
화학식 1Formula 1
상기 화학식 1에서: R은 수소원자 또는 메틸기를 나타내고; X는 할로겐원자를 나타낸다.In Chemical Formula 1, R represents a hydrogen atom or a methyl group; X represents a halogen atom.
이와 같은 본 발명을 더욱 상세하게 설명하면 다음과 같다.The present invention will be described in more detail as follows.
본 발명에 따른 상기 화학식 1로 표시되는 이미다졸리늄 화합물은 신규 화합물로서, 항균활성은 물론 UV 경화특성을 가지고 있어 기질 표면에 무용제 형태로 코팅 처리한 후 UV로 경화시키면 상기 화학식 1로 표시되는 이미다졸리늄 화합물이 고분자화(polymerization)되어 기질 표면에 고분자 막을 형성하게 된다. 또한, 형성된 고분자 막은 기질 표면에 균일하게 도포되어 있어 적용기질 전표면에서 균일한 항균활성력을 보이게 되며, 또한 항균물질과 코팅액 조성물이 서로 화학적으로 결합되어 있어 장기간이 소요되더라도 우수한 항균활성력을 지속시킬 수 있다.The imidazolinium compound represented by Chemical Formula 1 according to the present invention is a novel compound, and has antibacterial activity as well as UV curing properties. The imidazolinium compound is polymerized to form a polymer film on the surface of the substrate. In addition, the formed polymer membrane is uniformly coated on the surface of the substrate, and thus exhibits uniform antimicrobial activity on the entire surface of the applied substrate. Also, since the antimicrobial substance and the coating liquid composition are chemically bonded to each other, the excellent antimicrobial activity is maintained even if it takes a long time. You can.
본 발명에 따른 상기 화학식 1로 표시되는 이미다졸리늄 화합물을 구체적으로 예시하면 다음과 같다 :Specific examples of the imidazolinium compound represented by Chemical Formula 1 according to the present invention are as follows:
1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 할로겐화물,1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium halide,
1,3-비스[11-[(1-옥소-2-메틸-2-프로페닐)-옥시]운데실]이미다졸리늄 할로겐화물.1,3-bis [11-[(1-oxo-2-methyl-2-propenyl) -oxy] undecyl] imidazolinium halide.
또한, 상기 화학식 1로 표시되는 이미다졸리늄 화합물의 제조방법은 다음에 서 설명한 바와 같은 2 단계 반응(two-step reaction)으로 용이하게 제조할 수 있다 : 먼저, 할로겐을 포함하지 않는 일반적인 유기용매에서 이미다졸과 11-할로운데칸-1-올(11-haloundecan-1-ol)의 반응으로 사차 암모늄 염 중간체들을 합성 한다. 그리고, 과량의 아크릴로일 클로라이드 또는 메타크릴로일 클로라이드를 반응시켜 목적하는 상기 화학식 1로 표시되는 화합물을 합성한다.In addition, the method for preparing the imidazolinium compound represented by Chemical Formula 1 may be easily prepared by a two-step reaction as described below: First, a general organic solvent containing no halogen Quaternary ammonium salt intermediates are synthesized by the reaction of imidazole with 11-haloundecan-1-ol. An excess of acryloyl chloride or methacryloyl chloride is reacted to synthesize a compound represented by Chemical Formula 1 as desired.
또한, 이상에서 설명한 바와 같은 상기 화학식 1로 표시되는 신규 항균제는 항균활성이 요구되는 기질의 표면에 코팅 처리한 후 UV를 조사하는 방법으로 항균처리한다. 예컨대 상기 화학식 1로 표시되는 항균제 1 ∼ 10 중량%, 지방족 우레탄트리아크릴레이트 올리고머 30 ∼ 80 중량%, 히드록시프로필아크릴레이트 (HPA) 1 ∼ 10 중량%, 트리메틸프로판트리아크릴레이트 (TMPTA) 1 ∼ 10 중량%, 1,6-헥산디올디아크릴레이트 (HDDA) 5 ∼ 20 중량%, 트리프로필네오글리콜디아크릴레이트 (TPGDA) 5 ∼ 20 중량% 및 광개시제(예를 들면 Irgacure 184) 1 ∼ 5 중량% 등을 적절한 비율로 혼합하여 항균 코팅액을 제조한다.상기한 항균 코팅액 중에 함유되는 항균제의 함량이 1 중량% 미만이면 본 발명이 목적하는 항균효과를 얻을 수 없고, 10 중량%를 초과하여 과량 함유되더라도 현저한 항균력 증진효과를 얻을 수 없으므로 비경제적이라 할 수 있으며 그 밖에도 황변 등 기타 물성 저하현상이 나타날 수 있다. 그리고, 상기 화학식 1로 표시되는 항균제가 UV 경화에 의한 항균성 고분자막을 형성하도록 하기 위해, 본 발명에서는 전체 코팅액을 기준으로 지방족 우레탄트리아크릴레이트 올리고머, 히드록시프로필아크릴레이트 (HPA), 트리메틸프로판트리아크릴레이트 (TMPTA), 1,6-헥산디올디아크릴레이트 (HDDA), 트리프로필네오글리콜디아크릴레이트 (TPGDA)를 함유시킨다. 상기한 항균성 고분자막을 형성하기 위해 사용된 각 성분의 함량이 상기범위 미만으로 사용되면 경화된 도막의 가교결합 밀도가 낮아 경도와 내후성이 떨어지는 문제가 발생하게 되고, 각 사용성분의 함량 범위를 초과하여 사용되면 경화된 도막의 가교결합 밀도가 높아져 도막의 유연성이 떨어지는 문제가 있다. 그리고, 광개시제의 함량이 1 중량% 미만이면 코팅제의 경화가 이루어지지 않으며, 5 중량%를 초과하면 경화에 참여하지 못한 미반응 화학종이 잔류하여 냄새를 유발하고, 경도 및 내후성 등 도막 물성을 저하시킨다.또한, 항균 코팅액에는 용매를 함유시킬 수 있으나 무용제 상태로 사용하는 것이 바람직하다. 항균 코팅액을 항균활성이 요구되는 기질의 표면에 코팅하는 바 코팅방법은 공지방법에 의하며, 코팅한 후에 UV를 조사하면 상기 화학식 1로 표시되는 이미다졸리늄 화합물은 고분자로 전환되고 또 상기의 코팅 조성물들과 화학적 결합을 형성하여 기질표면에 견고하게 부착된다.In addition, the novel antimicrobial agent represented by the formula (1) as described above is treated with antimicrobial treatment by UV irradiation after coating the surface of the substrate requiring antimicrobial activity. For example, 1 to 10% by weight of the antimicrobial agent represented by Formula 1, 30 to 80% by weight of aliphatic urethane triacrylate oligomer, 1 to 10% by weight of hydroxypropyl acrylate (HPA), 1 to 3% of trimethylpropane triacrylate (TMPTA) 10% by weight, 5 to 20% by weight 1,6-hexanedioldiacrylate (HDDA), 5 to 20% by weight tripropylneoglycoldiacrylate (TPGDA) and 1 to 5% by weight photoinitiator (e.g. Irgacure 184) The antimicrobial coating solution is prepared by mixing% and the like in an appropriate ratio. If the content of the antimicrobial agent contained in the antimicrobial coating solution is less than 1% by weight, the antimicrobial effect desired by the present invention cannot be obtained, and the content of the antimicrobial agent is greater than 10% by weight. Even if it does not get a significant antimicrobial effect can be said to be uneconomical and other properties such as yellowing may appear. In addition, in order to form the antimicrobial polymer film of the antimicrobial agent represented by Chemical Formula 1 by UV curing, in the present invention, an aliphatic urethane triacrylate oligomer, hydroxypropyl acrylate (HPA), trimethyl propane triacryl based on the total coating solution Latex (TMPTA), 1,6-hexanedioldiacrylate (HDDA), tripropylneoglycoldiacrylate (TPGDA). When the content of each component used to form the antimicrobial polymer film is used below the above range, the crosslink density of the cured coating film is low, resulting in a problem of low hardness and weather resistance, and exceeds the content range of each component When used, there is a problem in that the crosslink density of the cured coating film becomes high, thereby decreasing the flexibility of the coating film. If the content of the photoinitiator is less than 1% by weight, the coating is not cured. If the content of the photoinitiator is greater than 5% by weight, unreacted species that do not participate in curing remain, causing odors, and deteriorating coating properties such as hardness and weather resistance. In addition, the antimicrobial coating liquid may contain a solvent, but is preferably used in a solvent-free state. Coating the antimicrobial coating solution on the surface of the substrate that requires antimicrobial activity is a coating method according to a known method, when the UV irradiation after coating is converted to the polymer imidazolinium compound represented by the formula (1) and the coating It forms a chemical bond with the compositions and adheres firmly to the substrate surface.
이상에서 설명한 바와 같이, 본 발명에 따른 상기 화학식 1로 표시되는 이미다졸리늄 화합물을 항균 코팅 처리한 기질에 대한 항균활성 및 항균 보유력에 대해 검색한 결과, 기질 전표면에서 고루게 활균활성을 검색할 수 있었고 물 속에 24 시간 방치하더라도 지속적으로 우수한 항균력을 보유하는 것을 검색할 수 있었다.As described above, as a result of searching for the antimicrobial activity and the antimicrobial retention ability of the substrate treated with the antimicrobial coating of the imidazolinium compound represented by the formula (1) according to the present invention, the activity on the surface of the substrate evenly search for It was possible to search for a good antibacterial activity even if left in water for 24 hours.
이와 같은 본 발명은 다음의 실시예에 의거하여 더욱 상세히 설명하겠는 바, 본 발명이 이에 한정되는 것은 아니다.Such a present invention will be described in more detail based on the following examples, but the present invention is not limited thereto.
실시예 1 : 1,3-비스(11-히드록시운데실)이미다졸리늄 브로마이드의 합성Example 1 Synthesis of 1,3-bis (11-hydroxyundecyl) imidazolinium bromide
이미다졸 3.41 g(50 mmol)과 11-브로모-1-운데칸올 25 g(100 mmol), 에탄올 50 mL의 혼합 용액을 100 ℃에서 48 시간 동안 교반하였다. 에탄올을 감압 증류한 후 반응혼합물을 에틸아세테이트 30 mL, 2M 브롬화수소 30 mL와, 물 30 mL로 연속하여 세척하고 감압 건조하여 흰색의 고체 생성물을 14.8 g 얻었다.A mixed solution of 3.41 g (50 mmol) of imidazole, 25 g (100 mmol) of 11-bromo-1-undecanol and 50 mL of ethanol was stirred at 100 ° C. for 48 hours. The ethanol was distilled off under reduced pressure, and the reaction mixture was washed successively with 30 mL of ethyl acetate, 30 mL of 2M hydrogen bromide, and 30 mL of water, and dried under reduced pressure to obtain 14.8 g of a white solid product.
수율 60%; m.p. 112∼115 ℃; IR(KBr) υmax3386(OH), 3103(Aromatic C-H), 2928, 2850(C-H) cm-1;1H NMR(CD3OD, 500 MHz) δ8.97(s, 1H,H-2), 7.57(s, 2H,H-4,5), 4.13(t, 4H, 2N+CH 2, J=7.2 Hz), 3.43(t, 4H, 2CH 2OH, J=6.6 Hz), 1.81(m, 4H), 1.42(m, 4H), 1.23(m, 28H).Yield 60%; mp 112-115 ° C .; IR (KBr) ν max 3386 (OH), 3103 (Aromatic CH), 2928, 2850 (CH) cm −1 ; 1 H NMR (CD 3 OD, 500 MHz) δ 8.97 (s, 1H, H -2), 7.57 (s, 2H, H -4,5), 4.13 (t, 4H, 2N + C H 2 , J = 7.2 Hz), 3.43 (t, 4H, 2C H 2 OH, J = 6.6 Hz), 1.81 (m, 4H), 1.42 (m, 4H), 1.23 (m, 28H).
실시예 2 : 1,3-비스(11-히드록시운데실)이미다졸리늄 클로라이드의 합성Example 2 Synthesis of 1,3-bis (11-hydroxyundecyl) imidazolinium chloride
이미다졸 3.41 g(50 mmol)과 11-브로모-1-운데칸올 25 g(100 mmol), 에탄올 50 mL의 혼합 용액을 100 ℃에서 48시간 동안 교반하였다. 에탄올을 감압 증류한 후 반응혼합물에 2M 염화수소 30 mL를 첨가한 후 30 분 동안 교반하였다. 반응용액으로부터 고체생성물을 여과한 다음 에틸아세테이트 40 mL와 물 20 mL로 세척하고 감압 건조하여 흰색의 고체 생성물을 13.5 g 얻었다.A mixed solution of 3.41 g (50 mmol) of imidazole, 25 g (100 mmol) of 11-bromo-1-undecanol, and 50 mL of ethanol was stirred at 100 ° C. for 48 hours. Ethanol was distilled under reduced pressure, and 30 mL of 2M hydrogen chloride was added to the reaction mixture, followed by stirring for 30 minutes. The solid product was filtered from the reaction solution, washed with 40 mL of ethyl acetate and 20 mL of water, and dried under reduced pressure to obtain 13.5 g of a white solid product.
수율 61%; m.p. 115 ℃; IR(KBr) υmax3376(OH), 3156(Aromatic C-H), 2920, 2851(C-H) cm-1;1H NMR(CD3OD, 300 MHz) δ7.90(s, 1H,H-2), 7.66(s, 2H,H-4,5), 4.22(t, 4H, 2N+CH 2, J=7.2 Hz), 3.53(t, 4H, 2CH 2OH, J=6.6 Hz), 1.89(m, 4H), 1.51(m, 4H), 1.31(m, 28H).Yield 61%; mp 115 ° C; IR (KBr) ν max 3376 (OH), 3156 (Aromatic CH), 2920, 2851 (CH) cm −1 ; 1 H NMR (CD 3 OD, 300 MHz) δ7.90 (s, 1H, H -2), 7.66 (s, 2H, H -4,5), 4.22 (t, 4H, 2N + C H 2 , J = 7.2 Hz), 3.53 (t, 4H, 2C H 2 OH, J = 6.6 Hz), 1.89 (m, 4H), 1.51 (m, 4H), 1.31 (m, 28H).
실시예 3 : 1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 브로마이드의 합성Example 3 Synthesis of 1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium bromide
1,3-비스(11-히드록시운데실)이미다졸리늄 브로마이드 8.5 g(17 mmol)과 히드로퀴논 0.22 g을 90 mL의 아크릴로일 클로라이드에 녹인 후 무수 황산 1 mL를 첨가하였다. 반응 용액을 50 ℃에서 6시간 동안 교반한 후 과량의 아크릴로일 클로라이드를 감압 증류하였다. 반응혼합물을 에틸아세테이트 40 mL에 녹인 다음 물 20 mL로 세척한 후 감압 건조해서 흰색의 고체 생성물을 5.8 g 얻었다.8.5 g (17 mmol) of 1,3-bis (11-hydroxyundecyl) imidazolinium bromide and 0.22 g of hydroquinone were dissolved in 90 mL of acryloyl chloride, followed by addition of 1 mL of anhydrous sulfuric acid. The reaction solution was stirred at 50 ° C. for 6 hours and then excess acryloyl chloride was distilled off under reduced pressure. The reaction mixture was dissolved in 40 mL of ethyl acetate, washed with 20 mL of water, and dried under reduced pressure to obtain 5.8 g of a white solid product.
수율 56%; m.p. 116.5∼118.6 ℃; IR(CHCl3) υmax3175(Aromatic C-H), 3026(C-H), 1742(C=O), 1676(C=C) cm-1;1H NMR(DMSO-d 6, 300 MHz) δ9.05(s, 1H,H-2), 7.65(s, 2H,H-4,5), 6.15(dd, 2H, 2trans-CH 2, Jgem=1.8, Jtrans=17.3 Hz), 5.95(dd, 2H, 2CH, Jcis=10.1 Hz), 5.75(dd, 2H, 2cis-CH 2), 4.00(t, 4H, 2N+CH 2, J=7.1 Hz), 3.87(t, 4H, 2CH 2O, J=6.6 Hz), 1.57(m, 4H), 1.37(m, 4H), 1.1(m, 28H);13C NMR(DMSO-d 6, 300 MHz) δ165.5, 135.9, 131.4, 128.4, 122.5, 64.1, 48.8, 40.3, 38.7, 29.2, 28.9, 28.8, 28.6, 28.3, 28.1, 25.4, 25.3Yield 56%; mp 116.5-118.6 ° C .; IR (CHCl 3 ) ν max 3175 (Aromatic CH), 3026 (CH), 1742 (C = O), 1676 (C = C) cm −1 ; 1 H NMR (DMSO- d 6 , 300 MHz) δ 9.05 (s, 1H, H -2), 7.65 (s, 2H, H -4,5), 6.15 (dd, 2H, 2 trans -C H 2 , J gem = 1.8, J trans = 17.3 Hz, 5.95 (dd, 2H, 2C H , J cis = 10.1 Hz), 5.75 (dd, 2H, 2 cis- C H 2 ), 4.00 (t, 4H, 2N + C H 2 , J = 7.1 Hz), 3.87 (t, 4H, 2C H 2 O, J = 6.6 Hz), 1.57 (m, 4H), 1.37 (m, 4H), 1.1 (m, 28H); 13 C NMR (DMSO- d 6 , 300 MHz) δ 165.5, 135.9, 131.4, 128.4, 122.5, 64.1, 48.8, 40.3, 38.7, 29.2, 28.9, 28.8, 28.6, 28.3, 28.1, 25.4, 25.3
실시예 4 : 1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 클로라이드의 합성Example 4 Synthesis of 1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium chloride
1,3-비스(11-히드록시운데실)이미다졸리늄 클로라이드 5 g(11 mmol)과 히드로퀴논 0.13 g을 50 mL의 아크릴로일 클로라이드에 녹인 후 무수 황산 1 mL를 첨가하였다. 반응 용액을 50 ℃에서 5 시간 동안 교반한 후 과량의 아크릴로일 클로라이드를 감압 증류하였다. 반응혼합물을 에틸아세테이트 40 mL에 녹인 다음 물 10 mL로 세척한 후 감압 건조하고 남은 반응혼합물을 관 크로마토그래피(클로로포름/메탄올=1/10 )로 분리 정제하여 시럽형태의 생성물을 3.7 g 얻었다.5 g (11 mmol) of 1,3-bis (11-hydroxyundecyl) imidazolinium chloride and 0.13 g of hydroquinone were dissolved in 50 mL of acryloyl chloride, followed by addition of 1 mL of anhydrous sulfuric acid. The reaction solution was stirred at 50 ° C. for 5 hours, and then excess acryloyl chloride was distilled off under reduced pressure. The reaction mixture was dissolved in 40 mL of ethyl acetate, washed with 10 mL of water, dried under reduced pressure, and the remaining reaction mixture was separated and purified by column chromatography (chloroform / methanol = 1/10) to obtain 3.7 g of a syrup-like product.
수율 60%; IR(CHCl3) υmax3175(Aromatic C-H), 3026(C-H), 1748(C=O), 1676(C=C) cm-1;1H NMR(DMSO-d 6, 300 MHz) δ9.23(s, 1H,H-2), 7.80(s, 2H,H-4,5), 6.34(dd, 2H, 2trans-CH 2, Jgem=1.8, Jtrans=17.3 Hz), 6.28(dd, 2H, 2CH, Jcis=10.1 Hz), 5.93(dd, 2H, 2cis-CH 2), 4.16(t, 4H, 2N+CH 2, J=7.1 Hz), 4.08(t, 4H, 2CH 2O, J=6.6 Hz), 1.78(m, 4H), 1.46(m, 4H), 1.23(m, 28H)Yield 60%; IR (CHCl 3 ) ν max 3175 (Aromatic CH), 3026 (CH), 1748 (C = O), 1676 (C = C) cm −1 ; 1 H NMR (DMSO- d 6 , 300 MHz) δ 9.23 (s, 1H, H -2), 7.80 (s, 2H, H -4,5), 6.34 (dd, 2H, 2 trans -C H 2 , J gem = 1.8, J trans = 17.3 Hz, 6.28 (dd, 2H, 2C H , J cis = 10.1 Hz), 5.93 (dd, 2H, 2 cis- C H 2 ), 4.16 (t, 4H, 2N + C H 2 , J = 7.1 Hz), 4.08 (t, 4H, 2C H 2 O, J = 6.6 Hz), 1.78 (m, 4H), 1.46 (m, 4H), 1.23 (m, 28H)
실시예 5 : 1,3-비스[11-[(1-옥소-2-메틸-2-프로페닐)-옥시]운데실]이미다졸리늄브로마이드의 합성Example 5 Synthesis of 1,3-bis [11-[(1-oxo-2-methyl-2-propenyl) -oxy] undecyl] imidazolinium bromide
1,3-비스(11-히드록시운데실)이미다졸리늄 브로마이드 5 g(10mmol)과 히드로퀴논 0.15 g을 60 mL의 메타크릴로일 클로라이드에 녹인 후 무수 황산 1 mL를 첨가하였다. 반응 용액을 50 ℃에서 5 시간 동안 교반한 후 과량의 메타크릴로일 클로라이드를 감압 증류하였다. 반응혼합물을 에틸아세테이트 40 mL에 녹인 다음 물 10 mL로 세척한 후 감압 건조하고 남은 반응혼합물을 관 크로마토그래피(클로로포름/메탄올=1/10 )로 분리 정제하여 시럽형태의 생성물을 3.6 g 얻었다.5 g (10 mmol) of 1,3-bis (11-hydroxyundecyl) imidazolinium bromide and 0.15 g of hydroquinone were dissolved in 60 mL of methacryloyl chloride, followed by addition of 1 mL of anhydrous sulfuric acid. The reaction solution was stirred at 50 ° C. for 5 hours, and excess methacryloyl chloride was distilled off under reduced pressure. The reaction mixture was dissolved in 40 mL of ethyl acetate, washed with 10 mL of water, dried under reduced pressure, and the remaining reaction mixture was separated and purified by column chromatography (chloroform / methanol = 1/10) to obtain 3.6 g of a syrup form product.
수율 58%; IR(CHCl3) υmax3185(Aromatic C-H), 3021(C-H), 1743(C=O), 1676(C=C) cm-1;1H NMR(DMSO-d 6, 300 MHz) δ9.20(s, 1H,H-2), 7.70(s, 2H,H-4,5), 5.83(d, 2H, 2trans-CH 2, Jgem=1.8, Hz), 5.48(d, 2H, 2cis-CH 2), 4.97(t, 4H, 2N+CH 2, J=7.1 Hz), 4.84(t, 4H, 2CH 2O, J=6.5 Hz), 1.67(m, 4H, 2CH 3 ), 1.57(m, 4H), 1.49(m, 4H), 1.17(m, 4H);13C NMR(DMSO-d 6, 300 MHz) δ: 167..8, 137.2, 137.1, 126.7, 123.7, 65.5, 50.1, 41.6, 39.9, 30.5, 30.1, 30.0, 29.8, 29.6, 29.3, 26.7, 26.6Yield 58%; IR (CHCl 3 ) ν max 3185 (Aromatic CH), 3021 (CH), 1743 (C═O), 1676 (C═C) cm −1 ; 1 H NMR (DMSO- d 6 , 300 MHz) δ 9.20 (s, 1H, H -2), 7.70 (s, 2H, H -4,5), 5.83 (d, 2H, 2 trans -C H 2 , J gem = 1.8, Hz), 5.48 (d, 2H, 2 cis- C H 2 ), 4.97 (t, 4H, 2N + C H 2 , J = 7.1 Hz), 4.84 (t, 4H, 2C H 2 0, J = 6.5 Hz), 1.67 (m, 4H, 2C H 3 ), 1.57 (m, 4H), 1.49 (m, 4H), 1.17 (m, 4H); 13 C NMR (DMSO- d 6 , 300 MHz) δ: 167..8, 137.2, 137.1, 126.7, 123.7, 65.5, 50.1, 41.6, 39.9, 30.5, 30.1, 30.0, 29.8, 29.6, 29.3, 26.7, 26.6
실시예 6 : PVC 바닥재(장판)위에 항균 코팅Example 6 Antibacterial Coating on PVC Flooring
본 발명의 항균 화합물 5 중량%를 지방족 우레탄트리아크릴레이트 올리고머 60 중량%, 광개시제로서 Irgacure 184 5 중량%, 트리메틸프로판트리아크릴레이트 (TMPTA) 5 중량%, 1,6-헥산디올디아크릴레이트(HDDA) 10 중량%, 트리프로필네오글리콜디아크릴레이트(TPGDA) 10 중량% 및 희석제인 히드록시프로필아크릴레이트(HPA) 5 중량%와 용매 없이 혼합하여 25 ℃에서 700 ∼ 800 cps의 점도로 유지한 다음, 이 배합액을 3 mm PVC 바닥재 위에 바코터(bar coater) #7을 이용하여 경화 후 두께가 15 ㎛ ∼ 18 ㎛ 되도록 코팅하였다. 그리고, 상기 방법으로 준비된 샘플은 80 watt/cm2중압 수은 램프 2개로 이루어진 UV 경화기를 컨베이어(convayer) 속도 6 m/min로 동일한 조건으로 경화처리 하였다. 이 때 램프(IL390B Light Bug)로부터 약 15cm 아래로 지나가는 PVC 코팅 샘플이 받는 광량은 1회 통과시 대략 400 mJ/cm2로 측정되었다.5% by weight of the antimicrobial compound of the present invention is 60% by weight of an aliphatic urethane triacrylate oligomer, 5% by weight of Irgacure 184 as a photoinitiator, 5% by weight of trimethylpropanetriacrylate (TMPTA), 1,6-hexanedioldiacrylate (HDDA) 10% by weight, 10% by weight of tripropyl neoglycol diacrylate and 5% by weight of hydroxypropyl acrylate (HPA), a diluent, are mixed without solvent and maintained at a viscosity of 700 to 800 cps at 25 ° C. The mixture was coated on a 3 mm PVC floor using a bar coater # 7 so as to have a thickness of 15 μm to 18 μm after curing. In addition, the sample prepared by the above method was cured under the same conditions at a conveyor speed of 6 m / min UV curing machine consisting of two 80 watt / cm 2 medium pressure mercury lamp. At this time, the amount of light received by the PVC coated sample passing down about 15 cm from the lamp (IL390B Light Bug) was measured to be approximately 400 mJ / cm 2 in one pass.
실험예 1 : UV 코팅 한 장판시료의 미생물에 대한 항균력 검색 IExperimental Example 1 Screening of Antimicrobial Activity against Microorganisms of a UV-Coated Plate Sample I
(1) 대상 미생물 준비(1) target microorganism preparation
실험 대상 미생물로서Bacillus subtilis(고초균), Proteus vulgaricus(프로테우스균)및 Staphylococcus aureus(포도상구균) 3종을 선정하고, 이들 각각의 미생물을 Nutrient Agar 배지 또는 TSB 배지에서 12 시간 배양하였으며, 접종원으로 사용할 때 기질에 대한 부착성을 고려하여 Tween 80 0.1%를 첨가하였다. 각각의 원액 내 미생물의 접종 밀도는 다음 표 1과 같다. Bacillus subtilis , Proteus vulgaricus and Staphylococcus aureus were selected as the microorganisms to be tested , and each of these microorganisms was incubated in Nutrient Agar medium or TSB medium for 12 hours. Tween 80 0.1% was added in consideration of adhesion to the substrate. Inoculation density of microorganisms in each stock solution is shown in Table 1 below.
(2) 시험내용 및 방법(2) Test contents and method
1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 브로마이드로 상기 실시예 6의 방법으로 항균 코팅된 장판 시료를 직경 35 mm의 원형으로 준비하였다. 그리고, 대조군으로 항균처리하지 않은 또다른 장판 시료를 준비하였다. 준비된 장판 시료를 100% 에탄올에 3 분간 담궈 살균 후 충분히 건조한 후에 시험에 사용하였다.A plate sample coated with antimicrobial coating of 1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium bromide by the method of Example 6 in the form of a diameter of 35 mm Ready. And another control plate sample which was not treated with antimicrobial was prepared as a control. The prepared jangpan sample was soaked in 100% ethanol for 3 minutes and sterilized sufficiently before being used for the test.
그리고, 상기에서 준비한 미생물액을 장판 시료 각각에 30 μL 씩 가하여 고르게 분사한 후 1 시간 방치하였다. 미생물 접종된 바닥면을 TSA 배지 표면에 눌러, 장판면의 미생물을 배지에 접종하였다. 30 ℃에서 2 일간 배양한 다음 콜로니수(Colony Count)를 계수하여 항균력을 평가하였으며, 그 결과는 다음 표 2에 나타내었다.And 30 microliters of the microbial fluid prepared above to each plate sample After spraying evenly, it was left for 1 hour. The bottom surface inoculated with the microorganisms was pressed onto the surface of the TSA medium to inoculate the long microorganisms into the medium. After culturing at 30 ° C. for 2 days, the antimicrobial activity was evaluated by counting colony counts, and the results are shown in Table 2 below.
상기 표 2에 따르면, 1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 브로마이드를 5 중량% 첨가하여 만든 배합액의 UV 코팅바닥재를 시료로 3종의 박테리아(Proteus, Bacillus, Staphylococcus)에 대하여 테스트한 결과 균주Bacillus subtilis에 대하여는 탁월한 항균력을 나타냈으며 나머지 2종의 균주에 대하여는 대체로 그 효능이 우수한 것으로 판명되었다.According to Table 2, the UV coating flooring material of the formulation prepared by adding 5% by weight of 1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium bromide As a result, three bacteria ( Proteus, Bacillus, Staphylococcus ) were tested as samples and showed excellent antimicrobial activity against strain Bacillus subtilis , and the efficacy of the other two strains was found to be excellent.
실험예 2 : UV 코팅 한 장판시료의 미생물에 대한 항균력 검색 ∏Experimental Example 2 Screening of Antimicrobial Activity against Microorganisms of a UV-Coated Plate Sample ∏
(1) 대상 미생물 준비(1) target microorganism preparation
시험대상 균주로Klepsiella pneumoniae(일명, 폐렴쌍구균)을 액상 배양하여 생육이 왕성한 상태의 2.0×106cfu/mL의 세균액을 제조하였다. Klepsiella pneumoniae (aka, pneumococcal pneumoniae) was cultured in the liquid phase as a test strain to prepare a 2.0 × 10 6 cfu / mL bacterial solution in a state of vigorous growth.
(2) 시험내용 및 방법(밀착법)(2) Test contents and method (contact method)
비교구으로서, 1-요오도프로피닐부틸카바메이트를 톨루엔과N-메틸피롤리디논에 녹인 40% 용액 즉, IP40(상품명)을 첨가형 방식으로 1%(A1), 2%(A2), 3%(A3), 8%(A8) 혼합하였고, 이를 PVC 바닥재 위에 코팅하여 시료로 준비하였다. 또한,시험구으로서 1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 브로마이드가 각각 5%(ID5), 8%(ID8) 함유된 코팅액을 제조하였고, 이 코팅액을 PVC 바닥재 위에 코팅한 후에 UV 조사하여 UV 코팅바닥재를 시료로 준비하였다. 준비된 시료 각각을 가로, 세로 3 cm로 절단하여 샘플을 제작하였다.As a control, a 40% solution of 1-iodopropynylbutylcarbamate dissolved in toluene and N -methylpyrrolidinone, i.e., IP40 (trade name) in an additive manner, 1% (A1), 2% (A2), 3 % (A3) and 8% (A8) were mixed, which was coated onto a PVC flooring to prepare a sample. In addition, 1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium bromide contained 5% (ID5) and 8% (ID8), respectively, as a test zone. A coating solution was prepared, and the coating solution was coated on a PVC flooring material, followed by UV irradiation to prepare a UV coating flooring material as a sample. Samples were prepared by cutting each prepared sample to 3 cm in length and width.
Nutrient agar(미국, difco사)배지를 멸균 상태의 배양접시(직경 8.7 cm)에 20 mL씩 분주하였다. 그리고, Nutrient agar 배양접시의 상부 뚜껑에 상기의 세균액을 0.5 mL 점적하고(접종밀도 1.0×106cfu/mL) 상기의 샘플을 점적된 세균액의 상부에 치상하여 밀착시킨 후 배지가 있는 배양접시를 뒤집어 덮었다. 28 ℃ 항온에서 24시간 배양하였다. 배양접시의 뚜껑에 있는 코팅 바닥재를 떼어내고 1 mL의 증류수로 세척한 후 뚜껑에 있는 세균액의 균수를 연속희석법에 의하여 측정하였다.Nutrient agar (Difco, USA) medium was dispensed in 20 mL in a sterile culture dish (8.7 cm in diameter). Then, 0.5 mL of the bacterial solution was added to the upper lid of the Nutrient agar culture dish (inoculation density 1.0 × 10 6 cfu / mL), and the sample was placed on the upper portion of the bacterial solution and adhered to the culture medium. Cover the dish upside down. Incubated for 24 hours at 28 ℃ constant temperature. After removing the coating bottom material on the lid of the culture dish and washing with 1 mL of distilled water, the number of bacteria in the lid was measured by the continuous dilution method.
다음 표 3은 상기한 바와 같은 바닥재에 항균력 검정 결과로서 균 사멸율을 측정하여 나타낸 것이다.The following Table 3 shows the bacterial kill rate as a result of the antimicrobial activity test on the flooring as described above.
상기 표 3에 따르면, 본 발명의 항균제로 UV 경화 처리된 장판 시험구(ID 시험구)는Klepsiella pneumoniae(폐렴 쌍구균)에 대하여 탁월한 항균력을 나타내었다. 특히 ID8의 장판 시험구에서는 비교구의 장판 시험구인 A8에서보다 생균수가 더욱 적었으며 따라서 사멸율 또한 더 높은 수치를 기록하였다.According to Table 3, the UV plate treated test plate (ID test) with the antimicrobial agent of the present invention showed an excellent antimicrobial activity against Klepsiella pneumoniae (pneumococcal dicocci ). Particularly, in ID8 jang plate, the number of viable cells was lower than that in A8 plate of comparison group, so the mortality rate was higher.
실험예 3 : 항균력의 지속성 테스트Experimental Example 3 Test of Persistence of Antimicrobial Activity
상기 실험예 2에서와 동일한 방법으로 제작된 바닥재 비교구(A8)와 시험구(ID8)를 각각 40 ℃에서 24시간 물 속에 방치한 후 건조하여Klepsiella pneumoniae(폐렴 쌍구균)에 대한 사멸율을 측정함으로써 항균력 지속성을 검색하였다. 그 결과, A8의 경우에는 70%, ID8는 99.9%의 사멸율을 나타내었다.By measuring the mortality rate for Klepsiella pneumoniae (pneumococcal pneumoniae) by drying the left wood comparison sphere (A8) and the test sphere (ID8) prepared in the same manner as in Experimental Example 2 and left in water for 24 hours at 40 ℃ Antimicrobial persistence was searched. As a result, the killing rate was 70% for A8 and 99.9% for ID8.
이와 같은 결과로 미루어 볼 때 첨가형 바닥재 A8는 상기 조건에서 코팅된 항균물질의 일부가 물에 용출되어 항균력이 감소됨을 알 수 있고, 본 발명의 항균제를 UV 경화처리한 바닥재 ID8는 항균물질들 사이의 견고한 고분자 결합을 통하여 항균물질이 용출되지 않음을 알 수 있었다.As a result, it can be seen that the additive-type flooring material A8 is a part of the antimicrobial material coated under the above conditions is eluted in water and the antimicrobial activity is reduced. It was found that the antimicrobial substance was not eluted through the solid polymer bond.
이상에서 상세히 설명한 바와 같이, 본 발명에 따른 신규 UV 경화형 항균제는 항균활성과 동시에 UV 경화 특성을 보유하고 있다. 이 물질을 항균처리가 요구되는 기질의 표면에 무용제 형태로 코팅한 후에 UV 처리하게 되면 상기 화학식 1로 표시되는 화합물과 코팅 조성물들 사이에 강한 고분자결합이 형성됨과 동시에 기질 표면에 부착되어 반영구적인 항균활성을 나타내게 되며, 또 항균 코팅액을 균일하게 코팅함으로써 기질 전 표면에서 고르게 항균력을 나타내게 된다. 특히 1,3-비스[11-[(1-옥소-2-프로페닐)-옥시]운데실]이미다졸리늄 브로마이드 고분자들이 고착된 바닥재를 사용하여 박테리아들에 대한 항균력을 검색 한 결과 낮은 농도에서도 4종의 박테리아들에 대하여 탁월한 항균력을 나타내었으며 이들 중Klepsiella pneumoniae에 대해서는 기존의 첨가형 항균제인 IP40 보다 더욱 우수한 항균력과 항균 지속성을 보였다.As described in detail above, the novel UV curable antimicrobial agent according to the present invention possesses UV curing properties at the same time as antibacterial activity. When this material is coated with a solvent-free form on the surface of the substrate requiring antimicrobial treatment and then UV treated, a strong polymer bond is formed between the compound represented by Formula 1 and the coating compositions, and is attached to the surface of the substrate. It shows activity, and by uniformly coating the antimicrobial coating solution, it shows the antimicrobial activity evenly on the entire surface of the substrate. In particular, it was found that the concentration of 1,3-bis [11-[(1-oxo-2-propenyl) -oxy] undecyl] imidazolinium bromide polymers was used to detect antibacterial activity against bacteria. Also showed excellent antibacterial activity against 4 kinds of bacteria.Klepsiella pneumoniaeAbout It showed better antimicrobial activity and antimicrobial persistence than the existing additive antimicrobial IP40.
따라서, 본 발명의 UV 경화형 항균제를 무용제 형태로 사용함으로써 기존의 첨가형 항균제의 짧은 항균 지속성, 인체에 대한 부작용 및 환경 오염등의 문제를 동시에 해소시킬 수 있다.Therefore, by using the UV-curable antimicrobial agent of the present invention in the form of a solvent-free, problems such as short antimicrobial persistence, side effects on the human body and environmental pollution of the existing additive antimicrobial agent can be solved at the same time.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0006599A KR100405030B1 (en) | 2001-02-10 | 2001-02-10 | New UV-curing antibacterial agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0006599A KR100405030B1 (en) | 2001-02-10 | 2001-02-10 | New UV-curing antibacterial agents |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020066429A KR20020066429A (en) | 2002-08-17 |
KR100405030B1 true KR100405030B1 (en) | 2003-11-10 |
Family
ID=27693970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0006599A KR100405030B1 (en) | 2001-02-10 | 2001-02-10 | New UV-curing antibacterial agents |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100405030B1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100135949A1 (en) | 2008-12-01 | 2010-06-03 | Becton, Dickinson And Company | Antimicrobial compositions |
US8821455B2 (en) | 2009-07-09 | 2014-09-02 | Becton, Dickinson And Company | Antimicrobial coating for dermally invasive devices |
US9352119B2 (en) | 2012-05-15 | 2016-05-31 | Becton, Dickinson And Company | Blood control IV catheter with antimicrobial properties |
US9579486B2 (en) | 2012-08-22 | 2017-02-28 | Becton, Dickinson And Company | Blood control IV catheter with antimicrobial properties |
US9695323B2 (en) | 2013-02-13 | 2017-07-04 | Becton, Dickinson And Company | UV curable solventless antimicrobial compositions |
US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US9750927B2 (en) | 2013-03-11 | 2017-09-05 | Becton, Dickinson And Company | Blood control catheter with antimicrobial needle lube |
US9327095B2 (en) | 2013-03-11 | 2016-05-03 | Becton, Dickinson And Company | Blood control catheter with antimicrobial needle lube |
US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US9675793B2 (en) | 2014-04-23 | 2017-06-13 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
US9789279B2 (en) | 2014-04-23 | 2017-10-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
US10232088B2 (en) | 2014-07-08 | 2019-03-19 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3678007A (en) * | 1971-08-23 | 1972-07-18 | Ppg Industries Inc | Metal salt complexes of imidazolium salts as curing agents for one part epoxy resins |
US3991202A (en) * | 1974-01-31 | 1976-11-09 | Janssen Pharmaceutica N.V. | Imidazolium salts |
US4831151A (en) * | 1985-04-26 | 1989-05-16 | Hoffmann-La Roche Inc. | Antimicrobial imidazolium derivatives |
EP0518458A1 (en) * | 1991-06-10 | 1992-12-16 | Texaco Chemical Company | Fatty imidazolium salts |
JPH10120690A (en) * | 1996-10-23 | 1998-05-12 | Japan Energy Corp | New quaternary imidazolium salt derivative and its production |
-
2001
- 2001-02-10 KR KR10-2001-0006599A patent/KR100405030B1/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3678007A (en) * | 1971-08-23 | 1972-07-18 | Ppg Industries Inc | Metal salt complexes of imidazolium salts as curing agents for one part epoxy resins |
US3991202A (en) * | 1974-01-31 | 1976-11-09 | Janssen Pharmaceutica N.V. | Imidazolium salts |
US4831151A (en) * | 1985-04-26 | 1989-05-16 | Hoffmann-La Roche Inc. | Antimicrobial imidazolium derivatives |
EP0518458A1 (en) * | 1991-06-10 | 1992-12-16 | Texaco Chemical Company | Fatty imidazolium salts |
JPH10120690A (en) * | 1996-10-23 | 1998-05-12 | Japan Energy Corp | New quaternary imidazolium salt derivative and its production |
Also Published As
Publication number | Publication date |
---|---|
KR20020066429A (en) | 2002-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100405030B1 (en) | New UV-curing antibacterial agents | |
JPH05140128A (en) | Quaternary ammonium salt resistant to polymerization by microorganism | |
JP2007302651A (en) | Photocurable monomer including imidazolium salt, antimicrobial and photocurable composition containing the monomer, and antimicrobial polymeric material produced from the composition | |
Gozzelino et al. | Quaternary ammonium monomers for UV crosslinked antibacterial surfaces | |
WO1991012282A1 (en) | Copolymers with inherent antimicrobial action | |
KR920005561B1 (en) | Biocidal compositions for industrial materials | |
PT95569A (en) | PROCESS FOR THE PREPARATION OF TIENILTIOUREIAS, ISOTIOUREIAS AND CARBODI-IMIDAS | |
US8436083B2 (en) | Multifunctional self-decontaminating surface coating | |
CA1051000A (en) | Imidazolidine-2,4-dione derivates and their use as pesticides | |
KR20070084373A (en) | Mold-resistant construction materials | |
JPH0848917A (en) | Antibacterial coating composition | |
US5786386A (en) | Antibacterial and fungicidal agent | |
US5889027A (en) | 3(2H)-furanone derivatives | |
US11548982B2 (en) | Active biocidal substances and production process thereof | |
KR100748041B1 (en) | Antibacterial imidazolium salt derivatives and antibacterial polymers prepared therefrom | |
US3711271A (en) | Method for controlling algae | |
EP0318400A1 (en) | Triazole derivatives, their use as fungicides and processes of preparation | |
US5118534A (en) | Alkylthioethanamine carbamic acid derivatives and their use in biocidal compositions | |
HUT53082A (en) | Insecticides, larvicides and aphicides and process for production of the applicable active substances consisting of heteroaryl-aryl-buthem or buthan derivatives | |
JPS625936A (en) | Fluorine-containing aromatic compound and antimicrobial and mildewproofing agent | |
JPH11279187A (en) | Phosphonium oligomers and production thereof, and antimicrobial agent, antimicrobial surface-treating agent and antimicrobial resin composition | |
US5155131A (en) | Alkylthioethanamine carbamic acid derivatives and their use in biocidal compositions | |
EP0169246A1 (en) | Parahydroxybenzoate compound | |
EP4050044A1 (en) | Compound, antimicrobial deodorant composition comprising same, and method for producing same | |
US3720769A (en) | Fungicidal sulfinylcyanoisothiazoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20091027 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |